| Literature DB >> 26568823 |
Nissar Shaikh1, Ayman El-Menyar2, Insolvisagan Natesa Mudali3, AbdelHakem Tabeb4, Hassan Al-Thani5.
Abstract
BACKGROUND: Necrotizing fasciitis (NF) is a rapidly progressive infection of fascia and subcutaneous tissue resulting in serious outcomes. We aimed to evaluate the clinical presentations, hospital course and outcomes of NF based on patient gender. PATIENTS AND METHODS: All patients admitted with NF were enrolled in the study over a 13-year period in the main tertiary hospital in Qatar. Clinical presentations, co-morbidities, severity and outcomes were analyzed and compared in male and female patients.Entities:
Keywords: Clinical presentation; Gender; Necrotizing fasciitis; Outcome; Qatar
Year: 2015 PMID: 26568823 PMCID: PMC4602355 DOI: 10.1016/j.amsu.2015.09.005
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Comparison of patients demography, clinical presentations and site of necrotizing fasciitis by gender.
| Overall | Female (n = 85) | Male (n = 246) | p-value | |
|---|---|---|---|---|
| Patients, n (%) | 331 | 85 (25.7%) | 246 (74.3%) | |
| Age (mean;year) | 50.8 ± 15.4 | 53.5 ± 16.3 | 50 ± 15 | 0.06 |
| Arabs | 183 (55.3%) | 76.5 | 48 | 0.001 for all |
| Trivial trauma | 43 (13.0%) | 10.1 | 17.3 | 0.15 |
| Intramuscular injection | 5 (1.5%) | 0.0 | 2.4 | 0.19 |
| No history of injury | 283 (85.5%) | 90.6 | 83.7 | 0.12 |
| Swelling | 237 (78%) | 80 | 77 | 0.65 |
| Pain | 208 (68.4%) | 72 | 67 | 0.4 |
| Fever | 203 (66.8%) | 65 | 68 | 0.62 |
| Duration of | 4 (1–30) | 4 (1–30) | 4 (1–30) | 0.8 |
| Number of debridements (median; range) | 2 (1–8) | 2 (1–7) | 2 (1–8) | 0.40 |
| Diabetes Mellitus | 167 (51.7%) | 57 | 50 | 0.23 |
| Coronary Artery Disease | 46 (14.2%) | 22 | 12 | 0.02 |
| Chronic Kidney Disease | 49 (15.2%) | 14.6 | 15.4 | 0.87 |
| Hypertension | 115 (35.6%) | 37.8 | 34.9 | 0.63 |
| Chronic liver Disease | 21 (6.5%) | 3.7 | 7.5 | 0.22 |
| Obesity | 15 (6%) | 8.2 | 3.3 | 0.05 |
| Smoking | 8 (2.4%) | 0.0 | 3.3 | 0.09 |
| Bedridden | 28 (8.5%) | 12.9 | 6.9 | 0.08 |
| Traumatic paraplegia | 3 (0.9%) | 0.0 | 0.2 | 0.30 |
| Lower limb | 175 (52.9%) | 51 | 54 | 0.62 |
| Perineum & genitalia | 113 (33.7%) | 15.2 | 40.1 | 0.002 |
| Abdomen & groin | 38 (11.5%) | 20 | 8.5 | 0.004 |
| Chest & breast | 8 (2.4%) | 3.5 | 2 | 0.43 |
| Face & neck | 21 (6.3%) | 8.5 | 7 | 0.24 |
| 0.59 for all | ||||
| Type I (Polybacterial) | 88 (31.9%) | 28.4 | 33.2 | |
| Type II (Monobacterial) | 158 (57.2%) | 58.1 | 56.9 | |
| Type III (Marine bacteria) | 0 | 0 | 0 | |
| Type IV (fungal)* | 30 (10.9%) | 13.5 | 9.9 | |
*Overlap with other bacteria could be there.
Laboratory findings by gender among patients with necrotizing fasciitis.
| Overall (n = 331) | Females (n = 85) | Males (n = 246) | P-value | |
|---|---|---|---|---|
| WBC (White blood cells) ( × 103/μl) | 16.2 ± 8.6 | 15 ± 8.7 | 16.5 ± 8.4 | 0.2 |
| Hb (Hemoglobin) (g/dl) | 12.1 ± 9.8 | 11.4 ± 10.8 | 12.4 ± 9.5 | 0.45 |
| PLT (Platelets) (109/l) | 269 ± 201 | 277 ± 148 | 266 ± 217 | 0.67 |
| Sodium (mEq/l) | 133.5 ± 5.6 | 133 ± 6 | 134 ± 5 | 0.47 |
| Glucose (mmol/l) | 12.5 ± 10.3 | 13.6 ± 8.7 | 12.1 ± 10.8 | 0.26 |
| Creatinine (μmol/l) | 97 (26–1263) | 87 (26–899) | 102 (26–1263) | 0.09 |
| Procalcitonin (ng/ml) | 10.5 (1–303) | 3.4 (1–182) | 4.6 (1–303) | 0.96 |
*Reference range.
Recipient and donor characteristics.
| Micro-organisms, n (%) | |
|---|---|
Streptococcus | 114 (38.4%) |
Staphylococcus | 109 (36.6%) |
| 34 (11.4%) | |
Pseudomonas | 23 (7.7%) |
Bacteroides | 61 (21.5%) |
Klebsiella | 23 (7.7%) |
Aeromonas | 4 (1.3%) |
Enterococcus | 14 (4.7%) |
Clostridium | 3 (1%) |
Proteus | 5 (1.7%) |
Morganella | 2 (0.7%) |
Prevotella | 6 (2%) |
Fungal | 30 (10.9%) |
Monobacterial | 158 (57.2%) |
Polybacterial | 88 (31.9%) |
Wound culture positive | 227 (69%) |
Blood culture positive | 65 (20%) |
Gram positive | 206 (69%) |
Gram negative | 92 (31%) |
Severity & outcomes of necrotizing fasciitis by gender.
| Overall (n = 331) | Females (n = 85) | Males (n = 246) | p-value | |
|---|---|---|---|---|
| SOFA score | 9 (2–21) | 8 (6–19) | 10 (2–21) | 0.02 |
| LRINEC ≥ 6 | 161 (54.8%) | 54 | 56 | 0.82 |
| NF Recurrence | 13 (3.9%) | 2.5% | 4.5% | 0.19 |
| ICU Stay (days) | 5.5 (1–75) | 5 (2–73) | 6 (1–75) | 0.2 |
| Hospital stay (days) | 16 (2–295) | 17 (2–115) | 16 (2–295) | 0.72 |
| Septic shock | 76 (27.8%) | 27.9% | 27.8% | 0.55 |
| Mortality | 85 (25.7%) | 27% (n = 23) | 25% (n = 62) | 0.73 |
Review of gender distribution and outcome from different nationalities.
| Author | Origin | Duration (years) | Total cases | Male:female ratio | Mortality |
|---|---|---|---|---|---|
| Huang et al., 2011 | Taiwan | 7 | 472 | 2:1 | 12.1% |
| Wang et al., 2014 | Taiwan | 8 | 91 | 2.8:1 | 20.9% |
| Singh et al., 2002 | India | – | 75 | 2.6:1 | 27% |
| Taviloglu et al., 2005 | Turkey | 16 | 98 | 1.8:1 | 35% |
| Martinschek et al., 2012 | Germany | 30 | 55 | 1.6:1 | 16.4% |
| Afifi et al., 2008 | Egypt | 13 | 37 | 2.7:1 | 43% |
| Frazee et al., 2008 | USA | 12 | 122 | 1.8:1 | 16.4% |
| Dworkin et al., 2009 | USA | 4 | 80 | 1.6:1 | 15% |
| Surahio et al., 2009 | Saudi Arabia | 0.5 | 35 | 6:1 | 11.5% |
| Present study | Qatar | 13 | 331 | 2.9:1 | 22% |